# Determining Optimal Dose and Duration of Diuretic Treatment in People With Acute Heart Failure (The DOSE-AHF Study)

> **NCT00577135** · PHASE3 · COMPLETED · sponsor: **Duke University** · enrollment: 308 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Furosemide-Q12 hour bolus
- **DRUG:** Furosemide-Continuous Infusion
- **DRUG:** Furosemide-Low Intensification
- **DRUG:** Furosemide-High Intensification

## Key facts

- **NCT ID:** NCT00577135
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2010-01
- **Final completion:** 2010-02
- **Target enrollment:** 308 (ACTUAL)
- **Last updated:** 2018-03-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00577135

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00577135, "Determining Optimal Dose and Duration of Diuretic Treatment in People With Acute Heart Failure (The DOSE-AHF Study)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00577135. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*